Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
TipRanks on MSN9h
Trinity Biotech’s CGM System Shows Breakthrough ImprovementsTrinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...
Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...
Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...
Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...
How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback